Court Overturns Insulet Verdict

A US appeals court reversed a 452 million dollar trade secret verdict that Insulet won against EOFlow. The court found that Insulet waited too long to file its lawsuit regarding insulin-pump technology.

Xurve View
Insights:
The United States Court of Appeals for the Federal Circuit is seen in Washington, D.C., U.S., August 30, 2020. REUTERS/Andrew Kelly

A United States appeals court overturned a $452M trade secret verdict that INSULET CORP won against rival EOFLOW CO LTD on Thursday afternoon. The decision reverses a 2024 Massachusetts federal jury award over insulin-pump technology. The ruling removes a major financial penalty for the South Korea-based medical device maker.